Health TrialsbyHealthPanel

Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy

ConditionAcute Ischemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSoochow University

About this trial

Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy.

This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Written informed consent by patient

Age ≥ 18 years

Acute ischemic stroke (with matching brain lesion on MR imaging)

Enrolment within 24 h after onset of stroke-related symptoms.

Disqualifiers

Pregnancy and / or breast-feeding.

Participation in an interventional study.

Patients refuse to participate in the research.

Trial population

Acute ischemic stroke patients within 24 h after onset of stroke-related symptoms.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • observational only- no intervention

    Other intervention

    observational only- no intervention

Treatment groups

400 Participants
are divided into 1 treatment group
Group A: Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy1 intervention

Trial outcomes

Primary outcomes

1

Rate of Major Adverse Cardiovascular Events

cardiovascular mortality (any mortality due to ischemic stroke, myocardial infarction, other cardiac diseases, or unobserved sudden death), ischemic stroke, myocardial infarction and unstable angina

Time frame
1 year

Secondary outcomes

1

Rate of Major Adverse Cardiovascular Events

ardiovascular mortality (any mortality due to ischemic stroke, myocardial infarction, other cardiac diseases, or unobserved sudden death), ischemic stroke, myocardial infarction and unstable angina

Time frame
90 days
2

Functional Outcome

Percentage of patients with modified Rankin Scale (mRS) scores (minimum 0 and maximum 5) 3 to 5, who are considered to be disabled.

Time frame
90 days
3

Rate of Ischemic Stroke

fatal and nonfatal ischemic stroke.

Time frame
1 year
4

Rate of Acute Coronary Syndrome

fatal and nonfatal myocardial infarction and unstable angina

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Soochow University

Lead sponsor

The First Affiliated Hospital of Soochow University

Sponsor institution

Source ClinicalTrials.gov
Apply now